Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function

Completed

Conditions studied: Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients

In brief

This is a multi-center, prospective, single cohort, observational study of pediatric heart transplant recipients designed to determine the impact of preformed versus de novo human leukocyte antigen (HLA) donor-specific antibodies (DSA), and antibodies to the self-antigens cardiac myosin and vimentin, on chronic allograft function. In addition, the investigators will explore mechanisms of action and predictors of DSA, rejection and altered pathophysiology.

Key facts

Study ID
NCT02752789
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
407
Starts
2014-07-15
Expected to finish
2019-11-01
Last updated by the study team
2019-11-29

Who can join

Age: any, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.